Open Access
Short Note
Volume 20, 2013
Article Number 55
Number of page(s) 3
Published online 19 December 2013
  1. Azoulay D, Vachapova V, Shihman B, Miler A, Karni A. 2005. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate. Journal of Neuroimmunology, 167(1–2), 215–218. [CrossRef] [PubMed] [Google Scholar]
  2. Benzel F, Erdur H, Kohler S, Frentsch M, Thiel A, Harms L, Wandinger KP, Rosche B. 2012. Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients. Journal of Helmintholology, 86(3), 339–347. [CrossRef] [Google Scholar]
  3. Correale J, Farez M. 2007. Association between parasite infection and immune responses in multiple sclerosis. Annals of Neurology, 61(2), 97–108. [CrossRef] [PubMed] [Google Scholar]
  4. Correale J, Farez M, Razzitte G. 2008. Helminth infections associated with multiple sclerosis induce regulatory B cells. Annals of Neurology, 64(2), 187–199. [CrossRef] [PubMed] [Google Scholar]
  5. Fleming JO, Isaak A, Lee JE, Luzzio CC, Carrithers MD, Cook TD, Field AS, Boland J, Fabry Z. 2011. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Multiple Sclerosis Journal, 17(6), 743–754. [CrossRef] [Google Scholar]
  6. Frota ER, Rodrigues DH, Donadi EA, Brum DG, Maciel DR, Teixeira AL. 2009. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. Neuroscience Letters, 460(2), 130–132. [CrossRef] [PubMed] [Google Scholar]
  7. Geisel O, Banas R, Schneider M, Hellweg R, Muller CA. 2013. Serum levels of brain-derived neurotrophic factor in patients with internet use disorder. Psychiatry Research, 209(3), 525–528. [CrossRef] [PubMed] [Google Scholar]
  8. Jones JL, Anderson JM, Phuah CL, Fox EJ, Selmaj K, Margolin D, Lake SL, Palmer J, Thompson SJ, Wilkins A, Webber DJ, Compston DA, Coles AJ. 2010. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain, 133(Pt 8), 2232–2247. [CrossRef] [PubMed] [Google Scholar]
  9. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? Journal of Experimental Medicine, 189(5), 865–870. [CrossRef] [Google Scholar]
  10. Liguori M, Fera F, Patitucci A, Manna I, Condino F, Valentino P, Telarico P, Cerasa A, Gioia MC, di Palma G, Quattrone A. 2009. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis. Brain Research, 1256, 123–128. [CrossRef] [PubMed] [Google Scholar]
  11. Luhder F, Gold R, Flugel A, Linker RA. 2013. Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models. Archivum Immunologiae et Therapiae Experimentalis, 61(2), 95–105. [CrossRef] [PubMed] [Google Scholar]
  12. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. 2005. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Annals of Neurology, 58(6), 840–846. [CrossRef] [PubMed] [Google Scholar]
  13. Thöne J, Ellrichmann G, Seubert S, Peruga I, Lee DH, Conrad R, Hayardeny L, Comi G, Wiese S, Linker RA, Gold R. 2012. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. American Journal of Pathology, 180(1), 267–274. [CrossRef] [Google Scholar]
  14. Weinstock-Guttman B, Zivadinov R, Tamaño-Blanco M, Abdelrahman N, Badgett D, Durfee J, Hussein S, Feichter J, Patrick K, Benedict R, Ramanathan M. 2007. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. Journal of Neuroimmunology, 188(1–2), 167–174. [CrossRef] [PubMed] [Google Scholar]
  15. Ziegenhorn AA, Schulte-Herbrüggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, Lang UE, Steinhagen-Thiessen E, Schaub RT, Hellweg R. 2007. Serum neurotrophins – a study on the time course and influencing factors in a large old age sample. Neurobiology of Aging, 28(9), 1436–1445. [CrossRef] [PubMed] [Google Scholar]
  16. Zuccato C, Cattaneo E. 2009. Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews Neurology, 5(6), 311–322. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.